271-95-4 | 1,2-Benzisoxazole

Packsize	Purity	Availability	Price	Discounted Price
200mg	96%	in stock	$14.00	$10.00
1g	96%	in stock	$27.00	$19.00
5g	96%	in stock	$93.00	$66.00
10g	96%	in stock	$179.00	$125.00
25g	96%	in stock	$351.00	$246.00

Description

• Catalog Number: AB57044
• Chemical Name: 1,2-Benzisoxazole
• CAS Number: 271-95-4
• Molecular Formula: C7H5NO
• Molecular Weight: 119.1207
• MDL Number: MFCD00005852
• SMILES: c1ccc2c(c1)onc2

Computed Properties

• Complexity: 105
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 9
• Hydrogen Bond Acceptor Count: 2
• XLogP3: 1.6

Literature

• 3-Benzyl-5-methyl-1,2-benzoxazole 2-oxide.

  Acta crystallographica. Section E, Structure reports online 20121001

• 3-Chloro-methyl-6,7-dimethyl-1,2-benz-oxazole.

  Acta crystallographica. Section E, Structure reports online 20121001

• Catalytic asymmetric hydrogenation of 3-substituted benzisoxazoles.

  Molecules (Basel, Switzerland) 20120606

• Benzisoxazole analogs as glycogen synthase activators, a patent evaluation (WO2011057956).

  Expert opinion on therapeutic patents 20120601

• Critical appraisal of lurasidone in the management of schizophrenia.

  Neuropsychiatric disease and treatment 20120101

• The role of paliperidone extended release for the treatment of bipolar disorder.

  Neuropsychiatric disease and treatment 20120101

• Genetic polymorphisms in CYP2E1: association with schizophrenia susceptibility and risperidone response in the Chinese Han population.

  PloS one 20120101

• Zonisamide: its pharmacology, efficacy and safety in clinical trials.

  Acta neurologica Scandinavica. Supplementum 20120101

• A divergent and selective synthesis of isomeric benzoxazoles from a single N-Cl imine.

  Organic letters 20111202

• Paliperidone: 3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]eth-yl}-9-hy-droxy-2-methyl-1,6,7,8,9,9a-hexa-hydro-pyrido[1,2-a]pyrimidin-4-one.

  Acta crystallographica. Section E, Structure reports online 20111101

• 3-[Chloro-(phen-yl)meth-yl]-6-methyl-1,2-benzoxazole.

  Acta crystallographica. Section E, Structure reports online 20111101

• Design, synthesis and SAR of indazole and benzoisoxazole containing 4-azetidinyl-1-aryl-cyclohexanes as CCR2 antagonists.

  Bioorganic & medicinal chemistry letters 20111015

• Biological evaluation of novel benzisoxazole derivatives as PPARδ agonists.

  Bioorganic & medicinal chemistry 20110515

• Optimization and in vitro toxicity evaluation of G4 PAMAM dendrimer-risperidone complexes.

  European journal of medicinal chemistry 20110301

• 3-{[6-(4-Chloro-phen-yl)imidazo[2,1-b][1,3,4]thia-diazol-2-yl]meth-yl}-1,2-benzoxazole.

  Acta crystallographica. Section E, Structure reports online 20110301

• Elucidation of a novel bioactivation pathway of a 3,4-unsubstituted isoxazole in human liver microsomes: formation of a glutathione adduct of a cyanoacrolein derivative after isoxazole ring opening.

  Drug metabolism and disposition: the biological fate of chemicals 20110201

• Synthesis of elastin based peptides conjugated to benzisoxazole as a new class of potent antimicrobials--A novel approach to enhance biocompatibility.

  European journal of medicinal chemistry 20110201

• Synthesis of a novel human PPARδ selective agonist and its stimulatory effect on oligodendrocyte differentiation.

  Bioorganic & medicinal chemistry letters 20110101

• Paliperidone extended-release: does it have a place in antipsychotic therapy?

  Drug design, development and therapy 20110101

• 3-{[5-(4-Bromo-phen-yl)imidazo[2,1-b][1,3,4]thia-diazol-2-yl]meth-yl}-1,2-benzoxazole.

  Acta crystallographica. Section E, Structure reports online 20110101

• Paliperidone ER in the Treatment of Borderline Personality Disorder: A Pilot Study of Efficacy and Tolerability.

  Depression research and treatment 20110101

• Clinical utility of the risperidone formulations in the management of schizophrenia.

  Neuropsychiatric disease and treatment 20110101

• Benzoxazinones as Human Peroxisome Proliferator Activated Receptor Gamma (PPARγ) Agonists: A Docking Study Using Glide.

  Indian journal of pharmaceutical sciences 20110101

• The effect of risperidone on D-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of schizophrenia.

  Journal of psychopharmacology (Oxford, England) 20100701

• Intramolecular Fe(II)-catalyzed N-O or N-N bond formation from aryl azides.

  Organic letters 20100618

• An efficient entry to 1,2-benzisoxazoles via 1,3-dipolar cycloaddition of in situ generated nitrile oxides and benzyne.

  Organic & biomolecular chemistry 20100607

• Iloperidone for the treatment of schizophrenia.

  The Annals of pharmacotherapy 20100501

• Zonisamide: a new drug for Parkinson's disease.

  Drugs of today (Barcelona, Spain : 1998) 20100401

• An improved synthesis of 1,2-benzisoxazoles: TBAF mediated 1,3-dipolar cycloaddition of nitrile oxides and benzyne.

  Chemical communications (Cambridge, England) 20100227

• Microwave-promoted synthesis of 3-amino-substituted 1,2-benzisoxazoles.

  Future medicinal chemistry 20100201

• New atypical antipsychotics for schizophrenia: iloperidone.

  Drug design, development and therapy 20100101

• Emerging treatments in the management of bipolar disorder - focus on risperidone long acting injection.

  Neuropsychiatric disease and treatment 20100101

• Once-monthly paliperidone injection for the treatment of schizophrenia.

  Neuropsychiatric disease and treatment 20100101

• Acute administration of clozapine and risperidone altered dopamine metabolism more in rat caudate than in nucleus accumbens: a dose-response relationship.

  Scientia pharmaceutica 20100101

• [The review of acute risperidone poisoning].

  Przeglad lekarski 20100101

• An Open-label Trial of Risperidone and Fluoxetine in Children with Autistic Disorder.

  Indian journal of psychological medicine 20100101

• 4-[(E)-(2,4-Difluoro-phen-yl)(hydroxy-imino)meth-yl]piperidinium picrate.

  Acta crystallographica. Section E, Structure reports online 20091001

• Theoretical investigations of the photochemical isomerizations of indoxazene and isoxazole.

  The Journal of organic chemistry 20090821

• Ethyl 6-(6-meth-oxy-2-naphth-yl)-2-oxo-4-(2-thien-yl)cyclo-hex-3-ene-1-carboxyl-ate.

  Acta crystallographica. Section E, Structure reports online 20090701

• 4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-[2-(2-methyl-4-oxo-6,7,8,9-tetra-hydro-4H-pyrido[1,2-a]pyrimidin-3-yl)eth-yl]piperidinium nitrate.

  Acta crystallographica. Section E, Structure reports online 20090701

• In thrombin stimulated human platelets Citalopram, Promethazine, Risperidone, and Ziprasidone, but not Diazepam, may exert their pharmacological effects also through intercalation in membrane phospholipids in a receptor-independent manner.

  Journal of chemical biology 20090601

• Synthesis of alkenyldiarylmethanes (ADAMs) containing benzo[d]isoxazole and oxazolidin-2-one rings, a new series of potent non-nucleoside HIV-1 reverse transcriptase inhibitors.

  European journal of medicinal chemistry 20090301

• A systematic review of quality of life and weight gain-related issues in patients treated for severe and persistent mental disorders: focus on aripiprazole.

  Neuropsychiatric disease and treatment 20090101

• Long-term safety and effectiveness of zonisamide in the treatment of epilepsy: a review of the literature.

  Neuropsychiatric disease and treatment 20090101

• HPLC method for simultaneous determination of impurities and degradation products in zonisamide.

  Indian journal of pharmaceutical sciences 20090101

• 3-(4-Chloro-phen-yl)-2,1-benzisoxazole-5-carbonyl chloride.

  Acta crystallographica. Section E, Structure reports online 20081201

• [Novel access to indazoles based on palladium-catalyzed amination chemistry].

  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20080701

• Kemp elimination: a probe reaction to study ionic liquids properties.

  The Journal of organic chemistry 20080502

• Absorption, metabolism, and excretion of paliperidone, a new monoaminergic antagonist, in humans.

  Drug metabolism and disposition: the biological fate of chemicals 20080401

• Paliperidone for schizophrenia.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20080301

• Reductive isoxazole ring opening of the anticoagulant razaxaban is the major metabolic clearance pathway in rats and dogs.

  Drug metabolism and disposition: the biological fate of chemicals 20080201

• Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophrenia.

  Neuropsychiatric disease and treatment 20080201

• Iloperidone: a new benzisoxazole atypical antipsychotic drug. Is it novel enough to impact the crowded atypical antipsychotic market?

  Expert opinion on investigational drugs 20080101

• RP-HPLC Estimation of Risperidone in Tablet Dosage Forms.

  Indian journal of pharmaceutical sciences 20080101

• Isolation of liver aldehyde oxidase containing fractions from different animals and determination of kinetic parameters for benzaldehyde.

  Indian journal of pharmaceutical sciences 20080101

• Paliperidone ER: a review of the clinical trial data.

  Neuropsychiatric disease and treatment 20071201

• Benefit of liquid crystal moieties in the MIP technique.

  Analytica chimica acta 20070515

• Novel base catalysed rearrangement of sultone oximes to 1,2-benzisoxazole-3-methane sulfonate derivatives.

  Beilstein journal of organic chemistry 20070101

• Atypical antipsychotics to treat the neuropsychiatric symptoms of dementia.

  Neuropsychiatric disease and treatment 20061201

• Decomposition and isomerization of 1,2-benzisoxazole: single-pulse shock-tube experiments, quantum chemical and transition-state theory calculations.

  The journal of physical chemistry. A 20061019

• Zonisamide - a review of experience and use in partial seizures.

  Neuropsychiatric disease and treatment 20060901

• Risperidone in the treatment of bipolar mania.

  Neuropsychiatric disease and treatment 20060601

• Development of hypoxia selective cytotoxins for cancer treatment: an update.

  Medicinal chemistry (Shariqah (United Arab Emirates)) 20060501

• Synthesis and anti-HIV activity of new alkenyldiarylmethane (ADAM) non-nucleoside reverse transcriptase inhibitors (NNRTIs) incorporating benzoxazolone and benzisoxazole rings.

  Bioorganic & medicinal chemistry 20060401

• Is subnanomolar binding affinity required for the in vivo imaging of acetylcholinesterase? Studies on 18F-labeled G379.

  Nuclear medicine and biology 20060101

• Successful treatment of six patients with neuroleptic malignant syndrome associated with myoglobulinemic acute renal failure.

  Renal failure 20060101

• Novel indole-based peroxisome proliferator-activated receptor agonists: design, SAR, structural biology, and biological activities.

  Journal of medicinal chemistry 20051229

• Identification of the structural requirements of the receptor-binding affinity of diphenolic azoles to estrogen receptors alpha and beta by three-dimensional quantitative structure-activity relationship and structure-activity relationship analysis.

  Journal of medicinal chemistry 20051201

• An efficient synthesis of a dual PPAR alpha/gamma agonist and the formation of a sterically congested alpha-aryloxyisobutyric acid via a Bargellini reaction.

  The Journal of organic chemistry 20051014

• Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: solution and X-ray crystallographic studies.

  Bioorganic & medicinal chemistry letters 20050502

• Mechanistic study of proton transfer and hysteresis in catalytic antibody 16E7 by site-directed mutagenesis and homology modeling.

  Bioorganic & medicinal chemistry 20050215

• Design, synthesis and evaluation of bicyclic benzamides as novel 5-HT1F receptor agonists.

  Bioorganic & medicinal chemistry letters 20041220

• Overview of Japanese experience-controlled and uncontrolled trials.

  Seizure 20041201

• A high-performance liquid chromatographic-atmospheric pressure chemical ionization-tandem mass spectrometric method for determination of risperidone and 9-hydroxyrisperidone in human plasma.

  Journal of analytical toxicology 20040901

• 1,2-benzisoxazole phosphorodiamidates as novel anticancer prodrugs requiring bioreductive activation.

  Journal of medicinal chemistry 20031204

• 2-(2,1-benzoxazol-3-yl)-3,5-dimethoxyphenol and 3-phenyl-2,1-benzoxazole.

  Acta crystallographica. Section C, Crystal structure communications 20030901

• Substituent effect on the reductive N-dearylation of 3-(indol-1-yl)-1,2-benzisoxazoles by rat liver microsomes.

  Drug metabolism and disposition: the biological fate of chemicals 20030801

• Isoxazole --> benzisoxazole rearrangement promoted cascade reactions affording stereodefined polycycles.

  Organic letters 20030220

• Stimulation by antipsychotic agents of mitogen-activated protein kinase (MAPK) coupled to cloned, human (h)serotonin (5-HT)(1A) receptors.

  Psychopharmacology 20020701

• Biocatalysis of isomerization of 1,2-benzisoxazole by bovine serum albumin in an organic solvent.

  Biotechnology and bioengineering 20010920